About SoberGroup

This author has not yet filled in any details.
So far SoberGroup has created 16 blog entries.

Spirituality is Key to Addiction Recovery

Dr. Cardwell Nuckols, a professional described as “one of the most influential clinical and spiritual trainers in North America,” recently led a presentation on the Rosebud Reservation. He’s worked in behavioral medicine for over 35 years. He’s viewed as one of the world’s leading experts on addiction and recovery. http://www.cnuckols.com/ Dr. Nuckols believes the only

Future Now Detox Launches Comprehensive Addiction Website, Offers Holistic Addiction Treatment

West Palm Beach, FL, March 14, 2018 --(PR.com)-- Future Now Detox is a proud provider of NAD treatment - Brain Restoration+ IV infusions. Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in every cell of the body. Vital for every cellular reaction, low levels of NAD can lead to poor mental health, decreased cognitive awareness,

Questions surround Florida’s rehab for addicted doctors and nurses

Claims: over-diagnosing, over-charging, conflicts. It's estimated roughly 10 percent of nurses in the U.S. have a dependency on drugs. Roughly 15 percent of doctors are considered addicted to drugs or alcohol. In Florida, the Professionals Resource Network (PRN) and the Intervention Project for Nurses (IPN) are state-contracted programs that help addicted practitioners and nurses get treatment while still being

Treatment for Depression and Alcoholism Discovered in Psychedelic Plant-Based Drug Ayahuasca

Ayahuasca is one of the most potent hallucinogenic drugs in the world. It might also be the key to a breakthrough treatment for alcoholism and depression. Like other drugs that serve traditional purposes in various cultures, such as peyote, piri piri or ibogaine, ayahuasca is naturally occurring and plant based. In South America, it’s usually

Nexalin Technology Demonstrates Success in the Treatment of Depression

Nexalin Technology is pleased to announce the initiation of clinical trials designed by the University of Pennsylvania to investigate the effectiveness of the Nexalin transcranial stimulation (TACS) for major depressive disorder. A subsidiary of Legacy Ventures International Inc. (OTC PINK: LGYV), Nexalin Technology is an FDA cleared medical device company that utilizes a safe, non-invasive,